Embree Financial Group’s Dimensional US Marketwide Value ETF DFUV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.08M Sell
74,114
-1,593
-2% -$83.6K 0.41% 49
2026
Q1
$3.67M Sell
75,707
-20,376
-21% -$1,000K 0.43% 49
2025
Q4
$4.48M Sell
96,083
-24,932
-21% -$1.13M 0.55% 38
2025
Q3
$5.41M Sell
121,015
-26,401
-18% -$1.15M 0.72% 29
2025
Q2
$6.23M Sell
147,416
-40,082
-21% -$1.61M 0.94% 23
2025
Q1
$7.73M Sell
187,498
-33,952
-15% -$1.43M 1.29% 18
2024
Q4
$9.06M Buy
221,450
+12,129
+6% +$515K 1.55% 15
2024
Q3
$8.73M Buy
209,321
+14,357
+7% +$580K 1.55% 15
2024
Q2
$7.66M Buy
194,964
+14,981
+8% +$593K 1.47% 16
2024
Q1
$7.36M Buy
179,983
+19,788
+12% +$756K 1.44% 16
2023
Q4
$5.96M Buy
+160,195
New +$5.51M 1.25% 17

Other funds holding DFUV

Embree Financial Group's DFUV Position: Q2 2026 in Review

Embree Financial Group reduced its Dimensional US Marketwide Value ETF (DFUV) stake by 2.1% in Q2 2026, selling an estimated $83.6K and leaving 74,114 shares worth $4.08M. The position accounts for 0.41% of the portfolio, ranked #49.

Embree Financial Group first reported a position in DFUV in Q4 2023 and has held it in 11 quarters since. The position peaked at $9.06M in Q4 2024. 147 funds tracked by Wall St. Rank hold DFUV as of Q2 2026.

  • Embree Financial Group held 74,114 shares of Dimensional US Marketwide Value ETF worth $4.08M as of Q2 2026.
  • Embree Financial Group sold 1,593 Dimensional US Marketwide Value ETF shares in Q2 2026, an estimated $83.6K.
  • Dimensional US Marketwide Value ETF made up 0.41% of Embree Financial Group's portfolio in Q2 2026, its #49 holding.
  • Embree Financial Group first reported a position in Dimensional US Marketwide Value ETF in Q4 2023 and has held it in 11 quarters since.
  • Embree Financial Group's Dimensional US Marketwide Value ETF position peaked at $9.06M in Q4 2024.
  • 147 funds tracked by Wall St. Rank held Dimensional US Marketwide Value ETF as of Q2 2026.

Based on Embree Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.